Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension
Justin K. Lui(Boston University), Elizabeth S. Klings, Deepa M. Gopal(Boston University), Michael P. LaValley(Boston University), Andreea M. Bujor(Boston University), Jasmine Vakhshoorzadeh(Boston University), Ruchika Sangani(Boston University), Kari R. Gillmeyer(Pulmonary and Allergy Associates), Renda Soylemez Wiener(Boston University), Marcin A. Trojanowski(Boston University)
Cited by 4
Related Papers
Screening for Lung Cancer
|CHEST Journal|2018|353
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
|American Journal of Respiratory and Critical Care Medicine|2014|256
Screening for Lung Cancer
|CHEST Journal|2021|240
Serum albumin concentration and heart failure risk
|American Heart Journal|2010|157